Veterinary Molecular Diagnostics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

The global veterinary molecular diagnostics market is expected to be valued at US$ 1.5 billion in 2026 and is projected to reach US$ 2.6 billion in 2033, expanding at a CAGR of 8.5% between 2026 and 2033.

The market is expanding steadily, driven by increasing awareness of zoonotic diseases, advancements in PCR and NGS technologies, and rising demand for accurate animal disease detection. Expansion of the livestock sector, government surveillance programs, and improved access to animal health care are also contributing to market growth.

Driver - Increasing Pet Ownership and Livestock Health Investments

Increasing pet ownership and growing investments in livestock health are major drivers of the veterinary molecular diagnostics market. According to the American Veterinary Medical Association (AVMA) and the American Pet Products Association (APPA), around 66% of U.S. households, or nearly 87 million households, owned a pet in 2023-24, up from 56% in 1988, reflecting a steady rise in demand for advanced veterinary diagnostics and preventive health care.

Globally, the Food and Agriculture Organization (FAO) reports continuous growth in livestock populations, with over 1.5 billion cattle and one billion pigs recorded in 2022, highlighting the scale of disease surveillance required for food safety and trade. In India, livestock contributed over 30% to the agriculture and allied sector’s GVA in 2021-22, emphasizing the sector’s economic importance. These trends indicate that as both companion and farm animals grow in number and value, molecular diagnostic tools offering faster and more accurate disease detection are increasingly adopted to protect animal and public health.

Restraint - Lack of Skilled Veterinary Diagnostic Professionals

In the U.S., the American Veterinary Medical Association (AVMA) identified more than 243 rural veterinary shortage areas across 46 states in 2025, signaling pronounced workforce gaps. In the U.K., the Royal College of Veterinary Surgeons (RCVS) projects that the supply of veterinarians in industry and research is expected to meet about 84% and 90% of demand, respectively, by 2035, highlighting chronic shortfalls in specialist roles required for advanced diagnostics.

These shortages are particularly critical for molecular diagnostics, which require technicians with expertise in PCR, NGS, and bioinformatics. Without sufficiently skilled personnel, the adoption of new platforms is hindered, sample throughput is limited, and operational delays increase, ultimately slowing market growth and limiting access to advanced veterinary testing services.

Opportunity - Demand for Point-of-Care (POC) Testing Solutions

The rising demand for point-of-care (POC) testing solutions represents a key opportunity in the market. This demand is driven by the global shift toward rapid, field-based disease detection. According to the World Organization for Animal Health (WOAH), over 60% of emerging infectious diseases in humans originate in animals, underscoring the need for real-time surveillance at the animal level.

The U.S. Department of Agriculture (USDA) and Centers for Disease Control and Prevention (CDC) have emphasized on-site diagnostic capabilities to enable faster responses to zoonotic outbreaks such as avian influenza and African swine fever. Similarly, the Food and Agriculture Organization (FAO) supports mobile and portable laboratory initiatives in Asia and Africa to strengthen livestock disease control and prevent cross-border spread. These efforts reflect the growing role of POC molecular diagnostics, as portable PCR and LAMP platforms allow veterinarians to obtain accurate results within hours, improving animal health management and biosecurity.

Product Insights

Reagents & consumables are the dominant product segment, holding around 59% share of the veterinary molecular diagnostics market in 2026, as they are required for every testing cycle and need continuous replenishment. Unlike instruments, which are generally one-time purchases, consumables such as PCR master mixes, primers, probes, and extraction kits are repeatedly used across diagnostic processes. According to the World Organization for Animal Health (WOAH), more than 50% of veterinary laboratories globally conduct molecular or PCR-based tests for disease surveillance, reflecting consistent demand for reagents and diagnostic kits.

The U.S. Department of Agriculture (USDA) and the Food and Agriculture Organization (FAO) also highlight that laboratory testing for diseases such as avian influenza and foot-and-mouth disease involves frequent reagent use due to high sample volumes. As a result, recurring testing requirements, ongoing disease monitoring, and biosecurity programs continue to support demand for reagents and consumables, making them the largest and most frequently purchased product segment in the market.

Technology Insights

PCR is the dominant technology segment, supported by its high sensitivity, rapid results, and broad pathogen detection capabilities. For instance, a study found that 92% of respondents regularly used PCR for equine pathogen detection in university and state veterinary laboratories.

The Food and Agriculture Organization also notes that PCR-based diagnostics are widely used in animal health surveillance to analyze sequence data and trace disease transmission in livestock across countries such as Brazil, China, India, Mexico, and South Africa. Because PCR tests can rapidly identify genetic material from bacterial, viral, and parasitic pathogens, they are integrated into numerous diagnostic workflows in veterinary laboratories, making PCR the preferred technology in this market.

North America Veterinary Molecular Diagnostics Market Trends

North America is likely to dominate the global market by holding around 39% share in 2026, driven by high pet ownership rates, advanced veterinary infrastructure, and well-established diagnostic capabilities. In the U.S., around 94 million households own pets as of 2025, reflecting strong demand for veterinary services and diagnostic testing.

Moreover, federal agencies such as the United States Department of Agriculture (USDA) and the Centers for Disease Control and Prevention (CDC) operate sophisticated animal health surveillance and diagnostic programs that rely heavily on molecular methods. This strong infrastructure, combined with high awareness of animal health and continued investment in veterinary care, supports faster adoption of molecular diagnostics for companion animals, livestock, and zoonotic diseases in North America compared with many other regions.

U.S. Veterinary Molecular Diagnostics Market Trends

The U.S. holds the largest share of the North American veterinary molecular diagnostics market, supported by advanced veterinary health care infrastructure, a large pet population, and well-established diagnostic laboratories. Increasing adoption of PCR-based testing, genetic diagnostics, pathogen identification, and antimicrobial resistance testing is driving demand across veterinary clinics, animal hospitals, and diagnostic centers.

The country also benefits from strong investment in veterinary research, animal health monitoring, and advanced diagnostic technologies. Rising pet health care spending, increasing focus on early disease detection, and growing livestock disease surveillance further support market growth. These factors continue to strengthen demand for accurate, rapid, and advanced molecular diagnostic solutions across the U.S. veterinary health care sector.

Europe Veterinary Molecular Diagnostics Market Trends and Insights

Europe represents a significant market for veterinary molecular diagnostics, supported by a large pet-owning population and substantial livestock sector. More than 90 million European households (around 46%) own at least one companion animal. At the same time, the region maintains large populations of agricultural animals, with around 133 million pigs and 74 million bovines at the end of 2023. This scale across both companion and production animals drives demand for advanced diagnostic solutions.

Moreover, the regulatory framework supported by the European Food Safety Authority (EFSA), along with animal health surveillance requirements, supports the adoption of molecular testing. Consequently, these factors make Europe an important and evolving market for veterinary molecular diagnostics.

Germany Veterinary Molecular Diagnostics Market Trends

Germany holds a leading position in the European veterinary molecular diagnostics market, supported by well-developed veterinary health care infrastructure, advanced diagnostic laboratories, and increasing adoption of molecular testing. Growing demand for rapid and accurate detection of infectious diseases, genetic disorders, and antimicrobial resistance is strengthening the use of PCR, sequencing, and other molecular diagnostic technologies across veterinary practices and laboratories.

The country also benefits from strong veterinary research capabilities and increasing awareness of preventive animal health care. Rising pet ownership, livestock disease surveillance, and regulatory emphasis on animal health further support market development. These factors collectively sustain demand for reliable and advanced veterinary molecular diagnostic solutions across Germany.

U.K. Veterinary Molecular Diagnostics Market Trends

The U.K. is expected to hold a significant share of the European market in 2026, supported by established veterinary healthcare infrastructure, advanced diagnostic laboratories, and increasing adoption of molecular testing technologies. Demand for rapid disease identification, pathogen detection, genetic testing, and antimicrobial resistance monitoring is increasing across veterinary clinics, research institutions, and livestock health care settings.

The country's strong focus on animal health surveillance and preventive veterinary care further supports market growth. Increasing pet ownership and spending on companion animal health care are also driving diagnostic adoption. Continued investment in laboratory capabilities and advanced testing technologies is expected to strengthen demand for veterinary molecular diagnostics across the U.K.

Asia Pacific Veterinary Molecular Diagnostics Market Trends

Asia Pacific represents the fastest-growing market, driven by expanding livestock production and rising pet ownership. Livestock production in the region has grown significantly, according to Food and Agriculture Organization data. Furthermore, countries such as China reported more than 116 million pets in 2023, including 58 million dogs and 60 million cats, contributing to increased demand for veterinary services.

These trends, including expanding livestock populations requiring disease surveillance and growing companion animal populations requiring preventive and diagnostic care, are creating strong demand for molecular diagnostic tools such as PCR and multiplex panels. Additionally, investments in diagnostic infrastructure and increased regulatory focus on animal health are further supporting the region's accelerated market growth.

China Veterinary Molecular Diagnostics Market Trends

China is projected to hold a major share of the Asia Pacific veterinary molecular diagnostics market in 2026, supported by a large livestock population, rising pet ownership, and expanding veterinary health care infrastructure. Increasing adoption of PCR-based testing, pathogen identification, and genetic diagnostics is strengthening demand across veterinary laboratories, animal hospitals, and livestock farms.

India Veterinary Molecular Diagnostics Market Trends

India is emerging as the fastest-growing market within Asia Pacific, supported by a large livestock population, increasing pet ownership, and expanding veterinary diagnostic infrastructure. Rising awareness of early disease detection, growing adoption of PCR-based testing, and increasing focus on livestock health and disease surveillance are driving demand across veterinary clinics, laboratories, and animal health care institutions.

The global veterinary molecular diagnostics market is highly competitive. Leading companies in the market are focusing on innovation and strategic expansion to meet growing diagnostic needs. Mergers, acquisitions, and collaborations remain key strategies to broaden global presence, enhance product portfolios, and develop advanced technologies such as real-time PCR and sequencing. These efforts enable firms to access new markets, strengthen veterinary partnerships, and leverage existing customer networks to support effective animal disease detection and surveillance.

Key Industry Developments:

• In June 2025, Zoetis launched AI Masses, an AI-powered cytologic capability for its Vetscan Imagyst platform, enhancing diagnostic precision for veterinarians. The new feature enabled automated detection and classification of cell masses, assisting in faster and more accurate cytology evaluations.
• In June 2025, bioMérieux launched VETFIRE, a cutting-edge testing solution for equine infectious respiratory diseases, expanding its presence in veterinary diagnostics. The new platform was developed to provide rapid and precise identification of major respiratory pathogens affecting horses, enabling early intervention and better disease management.